Association of Transplant Center With Survival Benefit Among Adults Undergoing Heart Transplant in the United States

Authors:

Abstract
Quiz Ref ID Heart transplant remains the definitive treatment for end-stage heart failure. Demand greatly exceeds supply and the median waiting time is longer than 9 months.1 Federal regulations require the Organ Procurement and Transplant Network (OPTN) make the “best use” of donor hearts by ranking candidates from “most to least medically urgent.”2 Because a sufficiently accurate and objective physiological score has not been developed, the OPTN uses a status-based system that ranks candidates largely according to the supportive therapy prescribed by their transplant center.3 This therapy-based system uses treatment intensity as a surrogate for medical urgency, relying on centers to select candidates and use appropriate advanced therapies for heart failure.

This publication has 25 references indexed in Scilit: